1-4 of 4
Lotte Bjerre Knudsen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates

Carsten F. Gotfredsen, Anne-Marie Mølck, Inger Thorup, Niels C. Berg Nyborg, Zaki Salanti, Lotte Bjerre Knudsen, Marianne O. Larsen
Journal: Diabetes
Diabetes 2014;63(7):2486–2497
https://doi.org/10.2337/db13-1087
Published: 14 June 2014
View articletitled, The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates
Open the PDF for The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates in another window
Includes: Supplementary data
Journal Articles

The Human GLP-1 Analog Liraglutide and the Pancreas: Evidence for the Absence of Structural Pancreatic Changes in Three Species

Niels C.B. Nyborg, Anne-Marie Mølck, Lars W. Madsen, Lotte Bjerre Knudsen
Journal: Diabetes
Diabetes 2012;61(5):1243–1249
https://doi.org/10.2337/db11-0936
Published: 13 April 2012
View articletitled, The Human GLP-1 Analog Liraglutide and the Pancreas: Evidence for the Absence of Structural Pancreatic Changes in Three Species
Open the PDF for The Human GLP-1 Analog Liraglutide and the Pancreas: Evidence for the Absence of Structural Pancreatic Changes in Three Species in another window
Journal Articles

Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not

Kirsten Raun, Pia von Voss, Carsten F. Gotfredsen, Valeria Golozoubova, Bidda Rolin, Lotte Bjerre Knudsen
Journal: Diabetes
Diabetes 2007;56(1):8–15
https://doi.org/10.2337/db06-0565
Published: 01 January 2007
View articletitled, Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not
Open the PDF for Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not in another window
Journal Articles

Systemic Administration of the Long-Acting GLP-1 Derivative NN2211 Induces Lasting and Reversible Weight Loss in Both Normal and Obese Rats

Philip J. Larsen, Christian Fledelius, Lotte Bjerre Knudsen, Mads Tang-Christensen
Journal: Diabetes
Diabetes 2001;50(11):2530–2539
https://doi.org/10.2337/diabetes.50.11.2530
Published: 01 November 2001
View articletitled, Systemic Administration of the Long-Acting GLP-1 Derivative NN2211 Induces Lasting and Reversible Weight Loss in Both Normal and Obese Rats
Open the PDF for Systemic Administration of the Long-Acting GLP-1 Derivative NN2211 Induces Lasting and Reversible Weight Loss in Both Normal and Obese Rats in another window